top of page

BioVenture VoiCes Episode 42: Nextech's Thilo Schroeder

  • 1 hour ago
  • 1 min read

An early investor in recent mega successes such as Revolution Medicines, Peloton, Blueprint Medicines, and Parabilis, he describes his investment philosophy and focus on precision oncology companies. Plus, his early life, getting hands on experience in biotech at Micromet, and learning from some of the top investors and scientific advisors in the industry.




Chapters

Early life and university - 0:58

Micromet - 11:18

PhD & SiROP - 13:50

Joining Nextech - 19:48

"Character forming years" - 27:31

Keeping a focus in oncology - 36:36

Investing at the PoC stage - 44:00

Investment themes - 52:49

The business side - 56:58

Personal life - 102:57

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

​

​Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page